Application of Stem Cell Therapy (SCT) to Covid-19: A Scientometric Assessment of Global Publications during 2020-21

Authors

  • B M Gupta Formerly with CSIR-NISTADS, New Delhi, INDIA.
  • Mallikarjun Kappi Government First Grade College, Jagalur, Karnataka, INDIA
  • K K Mueen Ahmed Phcog.Net # 9, First Floor, Vinnse Tower, Wheeler Road Extn., St. Thomas Town, Bangalore 560 084, INDIA.

DOI:

https://doi.org/10.5530/ijmedph.2022.3.22

Keywords:

Covid-19, Coronovirus 19, Cell Therapy, Stem Cell Applications, Global Publications, Bibliometrics, Scientometrics

Abstract

Objectives: The study makes a bibliometric evaluation of global publications on “Application of Stem Cell Therapy to Covid-19” during 2020-22. Methods: The published publications on this theme were searched, retrieved, and downloaded from the Elsevier’s Scopus international database and analyzed using bibliometric techniques based on select bibliometric indicators. The VOSviewer software and Biblioshiny application were used to construct and visualize bibliometric networks. Results: In all 1413 publications were indexed on “Application of Stem Cell Therapy to Covid-19” in the Scopus database till 30 December 2021. These publications registered an average of 18.03 citations per paper. Of these, the funded publications were 452(31.99%). In all, 91 countries, 690 organizations, and 1068 authors participated in global research and published in 317 journals. Among participating countries, China, the U.K., Italy, and India lead in publications output (with 185, 148, 127, and 110 papers) and China (58.38 and 3.24), France (47.0 and 2.61), Netherlands (46.63 and 2.59) and the U.K. (41.84 and 2.32) leads in citation impact. Among participating organizations, Tehran University of Medical Sciences, Iran (37 papers), Harvard Medical School, USA (36 papers), Memorial Sloan Kettering Cancer Center, USA (29 papers) and Shahid Beheshti University of Medical Sciences, Iran (26 papers) leads in publications productivity (with 37, 36, 29 and 26 papers) and Brigham and Women’s Hospital, USA (110.78 and 6.14), Massachusetts General Hospital, USA (81.35 and 4.51), Icahn School of Medicine at Mount Sinai, USA (78.95 and 4.38) and Harvard Medical School, USA (75.42 and 4.18) leads in citation impact. Among participating authors, K.K.Sahu (9 papers), J. Cerny (7 papers), M.A. Perales and M.Z. Ratajzak (7 papers each) leads in publication productivity and M. Mohty (37.0 and 2.05), P.R.M. Rocco (35.8 and 1.99), D.J. Weiss (33.5 and 1.86) and M.A. Perales (32.86 and 1.82) leads in citation impact. Stem Cell Reviews and Reports (35 papers), Frontiers in Immunology (32 papers), Bone Marrow Transplantation (30 papers) leads in publication productivity and Journal of Medical Virology (132.10), American Journal of Hematology (75.20), Aging and Disease (55.46) and Cell Stem Cell (33.14) leads in citation impact. Conclusion: The research is mainly dominated by North America and Western Europe, but with some contribution from China, India, Iran, and Brazil playing also an important role. The developing countries need to prioritize their research in this area and increase their collaboration with North America and Western Europe countries. The analysis will help scholars and policy-makers to take stock of the present situation and decide the future course of action on the “Application of Stem Cells in Covid-19”

Visualization of institutions collaboration Network

Downloads

Published

2022-11-18